RWML
AZN icon

RAFFA WEALTH MANAGEMENT, LLC’s AstraZeneca AZN Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.1K Buy
243
+18
+8% +$3.39K 0.01% 179
2026
Q1 		$44.4K Sell
225
-1
-0.4% -$193 0.01% 175
2025
Q4 		$41.5K Buy
226
+17
+8% +$2.98K 0.01% 179
2025
Q3 		$32.1K Buy
209
+19
+10% +$2.88K 0.01% 199
2025
Q2 		$26.5K Sell
190
-31
-14% -$4.34K 0.01% 230
2025
Q1 		$32.4K Sell
221
-51
-19% -$7.38K 0.01% 172
2024
Q4 		$35.6K Buy
272
+40
+17% +$5.6K 0.01% 173
2024
Q3 		$36.1K Hold
232
– – 0.01% 163
2024
Q2 		$36.2K Hold
232
– – 0.01% 227
2024
Q1 		$31.4K Sell
232
-9
-4% -$1.19K 0.01% 234
2023
Q4 		$32.4K Hold
241
– – 0.01% 157
2023
Q3 		$32.6K Buy
241
+57
+31% +$7.79K 0.01% 157
2023
Q2 		$26.3K Hold
184
– – 0.01% 177
2023
Q1 		$25.5K Hold
184
– – 0.01% 195
2022
Q4 		$24.9K Sell
184
-24
-12% -$3.01K 0.01% 189
2022
Q3 		$22.8K Sell
208
-2
-1% -$254 0.01% 192
2022
Q2 		$27.7K Buy
210
+2
+1% +$262 0.01% 178
2022
Q1 		$27.5K Sell
208
-62
-23% -$7.43K 0.01% 180
2021
Q4 		$31.5K Sell
270
-46
-15% -$5.41K 0.01% 184
2021
Q3 		$38K Buy
316
+38
+14% +$4.42K 0.01% 152
2021
Q2 		$33.2K Buy
278
+13
+5% +$1.43K 0.01% 164
2021
Q1 		$26.3K Buy
265
+28
+12% +$2.81K 0.01% 177
2020
Q4 		$23.6K Buy
237
+16
+7% +$1.7K 0.01% 171
2020
Q3 		$24.2K Buy
221
+17
+8% +$1.89K 0.01% 166
2020
Q2 		$21.6K Buy
204
+19
+10% +$1.96K 0.01% 167
2020
Q1 		$16.4K Buy
185
+60
+48% +$5.65K 0.01% 164
2019
Q4 		$12.5K Hold
125
– – ﹤0.01% 222
2019
Q3 		$11.1K Buy
+125
New +$10.8K ﹤0.01% 226
2019
Q2 		– Sell
-125
Closed -$10.1K – 797
2019
Q1 		$10.1K Hold
125
– – ﹤0.01% 192
2018
Q4 		$9.49K Hold
125
– – ﹤0.01% 213
2018
Q3 		$9.89K Hold
125
– – ﹤0.01% 220
2018
Q2 		$8.78K Hold
125
– – ﹤0.01% 214
2018
Q1 		$8.74K Hold
125
– – ﹤0.01% 210
2017
Q4 		$8.68K Hold
125
– – ﹤0.01% 200
2017
Q3 		$8.47K Hold
125
– – ﹤0.01% 211
2017
Q2 		$8.52K Hold
125
– – ﹤0.01% 205
2017
Q1 		$7.79K Sell
125
-49
-28% -$2.85K ﹤0.01% 188
2016
Q4 		$9.51K Buy
174
+4
+2% +$227 0.01% 180
2016
Q3 		$11.2K Hold
170
– – 0.01% 171
2016
Q2 		$10.3K Hold
170
– – 0.01% 170
2016
Q1 		$9.57K Hold
170
– – 0.01% 184
2015
Q4 		$11.5K Hold
170
– – 0.01% 163
2015
Q3 		$10.8K Hold
170
– – 0.01% 167
2015
Q2 		$10.8K Hold
170
– – 0.01% 161
2015
Q1 		$11.6K Hold
170
– – 0.01% 136
2014
Q4 		$12K Hold
170
– – 0.01% 131
2014
Q3 		$12.1K Buy
170
+45
+36% +$3.29K 0.01% 132
2014
Q2 		$9.29K Hold
125
– – 0.01% 145
2014
Q1 		$8.11K Sell
125
-45
-26% -$2.91K 0.01% 151
2013
Q4 		$12K Buy
+170
New +$9.23K 0.01% 131

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's AZN Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its AstraZeneca (AZN) stake by 8% in Q2 2026, buying an estimated $3.39K and bringing the position to 243 shares worth $46.1K. The position accounts for 0.01% of the portfolio, ranked #179.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in AZN in Q4 2013 and has held it in 50 quarters since. 498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 243 shares of AstraZeneca worth $46.1K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 18 AstraZeneca shares in Q2 2026, an estimated $3.39K.
  • AstraZeneca made up 0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #179 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in AstraZeneca in Q4 2013 and has held it in 50 quarters since.
  • 498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.